ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety Of Xeloda as Sequential Adjuvant Therapy After Chemotherapy in Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01662128
Recruitment Status : Recruiting
First Posted : August 10, 2012
Last Update Posted : August 10, 2012
Sponsor:
Information provided by (Responsible Party):
Zhang jin, Tianjin Medical University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2014
  Estimated Study Completion Date : June 2022